Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.
We shoot and we score. Up 1,133% since adding to Watch List @ $3.00.
Our second...
The Alkaline Water Company (WTER) Reports Record Second Quarter Revenue with 50% Year over...
$15.25 Million in Revenue is Best Quarter in Company History
SCOTTSDALE, Ariz., November 09, 2021–(BUSINESS WIRE)–The Alkaline Water Company...
Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we...
Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?
Adding Nautilus to the Watch List. Conference Call Transcript Below
New Street Targets at $15 per Share.
Peloton Plunges $9 Billion in Value, on a $805 Million Quarter!
Peloton just reported the $805 million for three months worth of business ended September. That's $9 million worth of fitness everyday. And...
The Rich get Richer and so do Their Shareholders!
Also known as "Billionaires Make Millionaires."
Been seeing a lot of grumbling about high-profile billionaires these days - and...
ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites
Gentleman, Start Your Engines?
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Society Pass News Archive
1-24-2023: Initiating Coverage on Society Pass (SOPA).
1-24-2023: Society Pass (SOPA) Research Reports
1-12-2023: Adding Society...
Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)
Shark Tank's Kevin O'Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
